feed,title,long_url,short_url
MedRxiv,"Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial",https://medrxiv.org/cgi/content/short/2022.03.30.22273206v1?rss=1,https://bit.ly/35tVeqp
MedRxiv,Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19,https://medrxiv.org/cgi/content/short/2022.03.31.22273226v1?rss=1,https://bit.ly/3qWl3qv
